Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CNPY3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
BRD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHPF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CABIN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHMP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR7113 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PES1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF4E2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
THAP7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
THAP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
INTS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDUFA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DESI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DUS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on